CO5251451A1 - COMBINATION CHEMOTHERAPY - Google Patents
COMBINATION CHEMOTHERAPYInfo
- Publication number
- CO5251451A1 CO5251451A1 CO00085238A CO00085238A CO5251451A1 CO 5251451 A1 CO5251451 A1 CO 5251451A1 CO 00085238 A CO00085238 A CO 00085238A CO 00085238 A CO00085238 A CO 00085238A CO 5251451 A1 CO5251451 A1 CO 5251451A1
- Authority
- CO
- Colombia
- Prior art keywords
- combination
- paclitaxel
- acetyldinaline
- carboplatin
- cancer
- Prior art date
Links
Abstract
Una combinación de agentes antineoplásicos que comprenden una cantidad antitumor de acetidinalina y una cantidad antitumor de paclitaxel y/o carboplatina. Una combinación de acuerdo con la Reivindicación 1 que comprende acetildinalina formulada como una cápsula. Una combinación de acuerdo con la Reivindicación 2 que comprende paclitaxel o una sal farmacéuticamente aceptable del mismo formulada como una solución estéril para infusión intravenosa. Una combinación de acuerdo con la Reivindicación 3 que comprende monoclorhidrato de paclitaxel.Una combinación que comprende acetildinalina y paclitaxel. Una combinación que comprende acetildinalina y carboplatina. Una combinación que comprende acetildinalina, paclitaxel y carboplatina. Un método para tratar el cáncer que comprende la administración a un animal que necesita del tratamiento de una cantidad antitumor de una combinación de las Reivindicaciones 1, 5, 6 y 7. Un método de acuerdo con la Reivindicación 8, caracterizado porque el cáncer tratado es cáncer de pulmón de célula no pequeña. Un método de acuerdo con la Reivindicación 9, que comprende la administración de acetildinalina en combinación con paclitaxel y/o carboplatina. 1Un método de acuerdo con la Reivindicación 8, caracterizado porque el cáncer tratado es cáncer de próstata.A combination of antineoplastic agents comprising an antitumor amount of acetidinaline and an antitumor amount of paclitaxel and / or carboplatin. A combination according to Claim 1 comprising acetyldinaline formulated as a capsule. A combination according to Claim 2 comprising paclitaxel or a pharmaceutically acceptable salt thereof formulated as a sterile solution for intravenous infusion. A combination according to Claim 3 comprising paclitaxel monohydrochloride A combination comprising acetyldinaline and paclitaxel. A combination comprising acetyldinaline and carboplatin. A combination comprising acetyldinaline, paclitaxel and carboplatin. A method for treating cancer comprising administration to an animal that needs to treat an antitumor amount of a combination of Claims 1, 5, 6 and 7. A method according to Claim 8, characterized in that the treated cancer is non-small cell lung cancer. A method according to Claim 9, which comprises the administration of acetyldinaline in combination with paclitaxel and / or carboplatin. 1 A method according to Claim 8, characterized in that the treated cancer is prostate cancer.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16488999P | 1999-11-10 | 1999-11-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5251451A1 true CO5251451A1 (en) | 2003-02-28 |
Family
ID=30442400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO00085238A CO5251451A1 (en) | 1999-11-10 | 2000-11-09 | COMBINATION CHEMOTHERAPY |
Country Status (2)
Country | Link |
---|---|
CO (1) | CO5251451A1 (en) |
ZA (1) | ZA200202780B (en) |
-
2000
- 2000-11-09 CO CO00085238A patent/CO5251451A1/en not_active Application Discontinuation
-
2002
- 2002-04-09 ZA ZA200202780A patent/ZA200202780B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200202780B (en) | 2003-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2175415T3 (en) | PHOSPHINATE-BASED MATRIX METALOPROTEASES INHIBITORS. | |
IL171607A (en) | Use of a botulinum toxin for the preparation of a medicament for treating sinus headache | |
GEP20053688B (en) | Substituted-Triazolopyrimidines as Anticancer Agents | |
CY1108629T1 (en) | Combination ET 743 with 5 Fluorouracil Pre-medicines for the therapeutic treatment of the heart | |
BR0312597A (en) | Drug Combinations for the Treatment of Neoplasms | |
EA200000282A1 (en) | METHOD OF INTRODUCTION OF A TAXAN TO A PATIENT WHO NEEDS TREATMENT BY A TAXAN, A METHOD OF TREATING A HUMAN BEAM Taksana | |
UY26456A1 (en) | COMPOUNDS THAT FIX THE G-QUADRUPLEX STRUCTURE OF TELOMERES, TRIAZINS FOR THE APPLICATION OF SUCH COMPOUNDS, THE USE OF SUCH COMPOUNDS AS PHARMACEUTICAL PRODUCTS AND INCLUDING THERAPEUTICAL ASSOCIATIONS. | |
EP1675465A4 (en) | Improved combination bacteriolytic therapy for the treatment of tumors | |
ES2123642T3 (en) | METHOD FOR THE TREATMENT OF CANCER BY JOINT THERAPY WITH 2'-HALOMETILIDENO DERIVATIVES AND A SPECIFIC ANTINEOPLASTIC AGENT OF PHASE S OR PHASE M. | |
WO2005117542A3 (en) | Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments | |
AR025885A1 (en) | DERIVATIVES OF INDOLIL-3-GLIOXILIC ACID WITH VALUABLE THERAPEUTIC PROPERTIES | |
ECSP045301A (en) | USE OF INDOLOPIRROLOCARBAZOL DERIVATIVE AND OTHER ANTI-TARGET AGENTS IN COMBINATION | |
CO5590913A2 (en) | ANTIVIRICAL COMBINATION THERAPY | |
ATE376824T1 (en) | USE OF HYALURONAN FOR PRODUCING A MEDICATION TO INCREASE THE EFFECTIVENESS OF CYTOTOXIC DRUGS | |
PE20011028A1 (en) | ONCOLYTIC COMBINATION OF ACETHYLDINALINE AND PACLITAXEL AND / OR CARBOPLATIN | |
AU4338501A (en) | Combination chemotherapy | |
CO5251451A1 (en) | COMBINATION CHEMOTHERAPY | |
MX2021011289A (en) | Compositions comprising pkm2 modulators and methods of treatment using the same. | |
BR0214564A (en) | Cancer Treatment Processes Using a Fpt Inhibitor and Antineoplastic Agents | |
ATE345805T1 (en) | CALCIUM TRIFLUOROCETATE WITH CYTOTOXIC EFFECT | |
ATE545423T1 (en) | AGENTS FOR THE TREATMENT OF LUNG CANCER | |
ES2031462T3 (en) | PROCEDURE TO PRODUCE 1-B-D-ARABINOFURANOSILCITOSINA-5'-STERARILFOSFATO MONOSODICO AND MONOHIDRATO OF THE SAME, AND PHARMACEUTICAL COMPOUND THAT CONTAINS THIS LAST. | |
Dettman et al. | Co-infusing glutathione and vitamin C during cancer treatment: a reply | |
EP1374873A4 (en) | The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy | |
Wang | Twice daily radiation therapy for carcinomas of the head and neck |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |